UnitedHealth Group (UNH)
NYSE: UNH
· Real-Time Price · USD
271.50
-0.31 (-0.11%)
At close: Aug 14, 2025, 3:59 PM
302.49
11.41%
Pre-market: Aug 15, 2025, 07:12 AM EDT
UnitedHealth Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Optumhealth Revenue | 105.36B | -108.35B | -90.87B | 39.81B | 5.73B | 4.92B | 44.86B | 36.15B | 30.11B | 23.24B | -56.75B | 16.97B | 13.96B |
| Optumhealth Revenue Growth | -197.24% | +19.24% | -328.26% | +594.49% | +16.39% | -89.02% | +24.07% | +20.09% | +29.56% | -140.95% | -434.43% | +21.51% | n/a |
| Optuminsight Revenue | 18.76B | 71.17B | 54.06B | 200.88B | 3.63B | 3.28B | 19.12B | 17.44B | 14.89B | 12.77B | 20.42B | 7.57B | 7.05B |
| Optuminsight Revenue Growth | -73.65% | +31.65% | -73.09% | +5433.75% | +10.67% | -82.85% | +9.67% | +17.12% | +16.57% | -37.45% | +169.73% | +7.34% | n/a |
| Optumrx Revenue | 133.23B | 14.58B | 12.2B | 10.8B | 689M | 612M | 154.27B | 147.93B | 114.09B | 68.19B | 8.34B | 39.47B | 41.13B |
| Optumrx Revenue Growth | +813.73% | +19.53% | +12.93% | +1467.78% | +12.58% | -99.60% | +4.29% | +29.66% | +67.32% | +717.50% | -78.87% | -4.04% | n/a |
| Unitedhealthcare Revenue | 298.21B | 99.77B | 91.31B | 87.5B | 8.92B | 8.37B | 333.75B | 304.07B | 268.91B | 245.48B | 51.18B | 211.14B | 194.41B |
| Unitedhealthcare Revenue Growth | +198.89% | +9.26% | +4.36% | +880.70% | +6.65% | -97.49% | +9.76% | +13.07% | +9.54% | +379.65% | -75.76% | +8.61% | n/a |
| Intersegment Eliminations Revenue | -150.89B | 249.74B | 222.9B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 233.23B | n/a | n/a |
| Intersegment Eliminations Revenue Growth | -160.42% | +12.04% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling, General, and Administrative Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |